Opioid-induced Constipation Market

List of Tables
Table 1. Opioid-induced Constipation Market Opportunities & Trends in Global Market
Table 2. Opioid-induced Constipation Market Drivers in Global Market
Table 3. Opioid-induced Constipation Market Restraints in Global Market
Table 4. Key Players of Opioid-induced Constipation in Global Market
Table 5. Top Opioid-induced Constipation Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Opioid-induced Constipation Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Opioid-induced Constipation Revenue Share by Companies, 2017-2022
Table 8. Global Companies Opioid-induced Constipation Product Type
Table 9. List of Global Tier 1 Opioid-induced Constipation Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Opioid-induced Constipation Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Opioid-induced Constipation Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Opioid-induced Constipation Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Opioid-induced Constipation Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Opioid-induced Constipation Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Opioid-induced Constipation Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Opioid-induced Constipation Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Opioid-induced Constipation Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Opioid-induced Constipation Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Opioid-induced Constipation Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Opioid-induced Constipation Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Opioid-induced Constipation Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Opioid-induced Constipation Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Opioid-induced Constipation Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Opioid-induced Constipation Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Opioid-induced Constipation Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Opioid-induced Constipation Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Opioid-induced Constipation Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Opioid-induced Constipation Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Opioid-induced Constipation Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca Opioid-induced Constipation Product Offerings
Table 32. AstraZeneca Opioid-induced Constipation Revenue (US$, Mn), (2017-2022)
Table 33. Takeda Pharmaceutical Corporate Summary
Table 34. Takeda Pharmaceutical Opioid-induced Constipation Product Offerings
Table 35. Takeda Pharmaceutical Opioid-induced Constipation Revenue (US$, Mn), (2017-2022)
Table 36. Bausch Health Corporate Summary
Table 37. Bausch Health Opioid-induced Constipation Product Offerings
Table 38. Bausch Health Opioid-induced Constipation Revenue (US$, Mn), (2017-2022)
Table 39. Abbott Corporate Summary
Table 40. Abbott Opioid-induced Constipation Product Offerings
Table 41. Abbott Opioid-induced Constipation Revenue (US$, Mn), (2017-2022)
Table 42. Bayer Corporate Summary
Table 43. Bayer Opioid-induced Constipation Product Offerings
Table 44. Bayer Opioid-induced Constipation Revenue (US$, Mn), (2017-2022)
Table 45. Boehringer Ingelheim Corporate Summary
Table 46. Boehringer Ingelheim Opioid-induced Constipation Product Offerings
Table 47. Boehringer Ingelheim Opioid-induced Constipation Revenue (US$, Mn), (2017-2022)
Table 48. C.B. Fleet Corporate Summary
Table 49. C.B. Fleet Opioid-induced Constipation Product Offerings
Table 50. C.B. Fleet Opioid-induced Constipation Revenue (US$, Mn), (2017-2022)
Table 51. Cosmo Pharmaceuticals Corporate Summary
Table 52. Cosmo Pharmaceuticals Opioid-induced Constipation Product Offerings
Table 53. Cosmo Pharmaceuticals Opioid-induced Constipation Revenue (US$, Mn), (2017-2022)
Table 54. Daewoong Corporate Summary
Table 55. Daewoong Opioid-induced Constipation Product Offerings
Table 56. Daewoong Opioid-induced Constipation Revenue (US$, Mn), (2017-2022)
Table 57. Daiichi Sankyo Corporate Summary
Table 58. Daiichi Sankyo Opioid-induced Constipation Product Offerings
Table 59. Daiichi Sankyo Opioid-induced Constipation Revenue (US$, Mn), (2017-2022)
Table 60. GlaxoSmithKline Corporate Summary
Table 61. GlaxoSmithKline Opioid-induced Constipation Product Offerings
Table 62. GlaxoSmithKline Opioid-induced Constipation Revenue (US$, Mn), (2017-2022)
Table 63. Ironwood Pharmaceuticals Corporate Summary
Table 64. Ironwood Pharmaceuticals Opioid-induced Constipation Product Offerings
Table 65. Ironwood Pharmaceuticals Opioid-induced Constipation Revenue (US$, Mn), (2017-2022)
Table 66. Johnson and Johnson Corporate Summary
Table 67. Johnson and Johnson Opioid-induced Constipation Product Offerings
Table 68. Johnson and Johnson Opioid-induced Constipation Revenue (US$, Mn), (2017-2022)
Table 69. Merck Corporate Summary
Table 70. Merck Opioid-induced Constipation Product Offerings
Table 71. Merck Opioid-induced Constipation Revenue (US$, Mn), (2017-2022)
Table 72. Mundipharma Corporate Summary
Table 73. Mundipharma Opioid-induced Constipation Product Offerings
Table 74. Mundipharma Opioid-induced Constipation Revenue (US$, Mn), (2017-2022)
Table 75. Nektar Therapeutics Corporate Summary
Table 76. Nektar Therapeutics Opioid-induced Constipation Product Offerings
Table 77. Nektar Therapeutics Opioid-induced Constipation Revenue (US$, Mn), (2017-2022)
Table 78. Pfizer Corporate Summary
Table 79. Pfizer Opioid-induced Constipation Product Offerings
Table 80. Pfizer Opioid-induced Constipation Revenue (US$, Mn), (2017-2022)
Table 81. Progenics Pharmaceuticals Corporate Summary
Table 82. Progenics Pharmaceuticals Opioid-induced Constipation Product Offerings
Table 83. Progenics Pharmaceuticals Opioid-induced Constipation Revenue (US$, Mn), (2017-2022)
Table 84. Shionogi Corporate Summary
Table 85. Shionogi Opioid-induced Constipation Product Offerings
Table 86. Shionogi Opioid-induced Constipation Revenue (US$, Mn), (2017-2022)
Table 87. SLA Pharma Corporate Summary
Table 88. SLA Pharma Opioid-induced Constipation Product Offerings
Table 89. SLA Pharma Opioid-induced Constipation Revenue (US$, Mn), (2017-2022)
Table 90. Sucampo Corporate Summary
Table 91. Sucampo Opioid-induced Constipation Product Offerings
Table 92. Sucampo Opioid-induced Constipation Revenue (US$, Mn), (2017-2022)
Table 93. Synergy Pharmaceuticals Corporate Summary
Table 94. Synergy Pharmaceuticals Opioid-induced Constipation Product Offerings
Table 95. Synergy Pharmaceuticals Opioid-induced Constipation Revenue (US$, Mn), (2017-2022)
Table 96. Theravance Corporate Summary
Table 97. Theravance Opioid-induced Constipation Product Offerings
Table 98. Theravance Opioid-induced Constipation Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Opioid-induced Constipation Segment by Type in 2021
Figure 2. Opioid-induced Constipation Segment by Application in 2021
Figure 3. Global Opioid-induced Constipation Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Opioid-induced Constipation Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Opioid-induced Constipation Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Opioid-induced Constipation Revenue in 2021
Figure 8. By Type - Global Opioid-induced Constipation Revenue Market Share, 2017-2028
Figure 9. By Application - Global Opioid-induced Constipation Revenue Market Share, 2017-2028
Figure 10. By Region - Global Opioid-induced Constipation Revenue Market Share, 2017-2028
Figure 11. By Country - North America Opioid-induced Constipation Revenue Market Share, 2017-2028
Figure 12. US Opioid-induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Opioid-induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Opioid-induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Opioid-induced Constipation Revenue Market Share, 2017-2028
Figure 16. Germany Opioid-induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 17. France Opioid-induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Opioid-induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Opioid-induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Opioid-induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Opioid-induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Opioid-induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Opioid-induced Constipation Revenue Market Share, 2017-2028
Figure 24. China Opioid-induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Opioid-induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Opioid-induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Opioid-induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 28. India Opioid-induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Opioid-induced Constipation Revenue Market Share, 2017-2028
Figure 30. Brazil Opioid-induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Opioid-induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Opioid-induced Constipation Revenue Market Share, 2017-2028
Figure 33. Turkey Opioid-induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Opioid-induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Opioid-induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Opioid-induced Constipation Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca Opioid-induced Constipation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Takeda Pharmaceutical Opioid-induced Constipation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bausch Health Opioid-induced Constipation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Abbott Opioid-induced Constipation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bayer Opioid-induced Constipation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Boehringer Ingelheim Opioid-induced Constipation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. C.B. Fleet Opioid-induced Constipation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Cosmo Pharmaceuticals Opioid-induced Constipation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Daewoong Opioid-induced Constipation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Daiichi Sankyo Opioid-induced Constipation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. GlaxoSmithKline Opioid-induced Constipation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Ironwood Pharmaceuticals Opioid-induced Constipation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Johnson and Johnson Opioid-induced Constipation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Merck Opioid-induced Constipation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Mundipharma Opioid-induced Constipation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Nektar Therapeutics Opioid-induced Constipation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Pfizer Opioid-induced Constipation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Progenics Pharmaceuticals Opioid-induced Constipation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Shionogi Opioid-induced Constipation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. SLA Pharma Opioid-induced Constipation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Sucampo Opioid-induced Constipation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Synergy Pharmaceuticals Opioid-induced Constipation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 59. Theravance Opioid-induced Constipation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)